Company: DMAAR
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001213900-25-111704
Chunk: 0

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation
of Principal Financial and Accounting Officer

On October 8, 2025, Glenn Worman, the Chief Financial Officer and principal financial and accounting officer of Drugs Made In America
Acquisition Corp. (the “ Company”) delivered to the Company a notice of resignation from his position as Chief Financial Officer
and principal financial and accounting officer of the Company. Mr. Worman’s resignation is effective October 8, 2025. Mr. Worman
indicated that his resignation was not the result of any disagreement with the Company regarding its operations, policies, practices or
otherwise.

Appointment
of Principal Financial and Accounting Officer

On
November 17, 2025, the Company appointed Saleem Elmasri as Chief Financial Officer and principal financia and accounting officer of
the Company and entered into a Master Services Agreement (the “ Consulting Agreement

Mr.
Elmasri’s biographical information is as follows:

Mr.
Elmasri is a CPA and seasoned business professional with 20 years of experience in financial and management consulting. Mr. Elmasri began
his career at PricewaterhouseCoopers(“ PwC

From
September 2020 to the present, he has served as the Managing Partner at Titan Advisory Services LLC, a boutique advisory firm focused
on providing collaborative and customized financial operations and CFO services to early-stage companies. From June 2019 to August 2020,
he was Managing Director at DLA LLC. From March 2018 to June 2019, he worked as Senior Director for Pine Hill Group LLC, a boutique accounting
and transaction advisory firm. From September 2007 to March 2018, Mr. Elmasri advanced through a series of progressively responsible
roles, culminating in the position of Senior Manager for PricewaterhouseCoopers LLP, a Big-4 Accounting and Global Professional Services
firm. Mr. Elmasri received B. S. degrees in Accounting and Finance from Rutgers University in 2007.

In
connection with his appointment, Mr. Elmasri is expected to enter into an Indemnity Agreement, a LetterAgreement and a Registration Rights
Agreement with the Company on the same terms as the other directors and officers of the Company that executed similar agreements at the
time of the consummation of the Company’s initial public